|
|
Article: Studies from Yokohama City University, Department of Clinical Oncology have provided new information about allergic reactions therapy.(Report)
- Article from:
- Cancer Weekly
- Article date:
- September 15, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
New research, 'Allergic reactions to oxaliplatin in a single institute in Japan,' is the subject of a report. According to a study from Yokohama, Japan, "Allergic reactions to oxaliplatin can be severe and are an important cause of discontinuation of treatment. A retrospective review was performed for 105 patients who received FOLFOX regimens between May 2005 and June 2007."
"Twenty-five cases (23.8%) of allergic reactions were identified, including 9 late onset reactions (8.6%) and 16 immediate reactions (15.2%). Severe allergy (Grades 3 and 4) occurred in seven patients (6.7%). Re-introduction of FOLFOX was attempted for seven immediate onset patients with a ...